ARMISTICE CAPITAL, LLC - 31 Mar 2025 SCHEDULE 13G Report for HELIUS MEDICAL TECHNOLOGIES, INC. Class A Common Stock, $0.001 par value per share (HSDT)

Filing Manager
ARMISTICE CAPITAL, LLC
Reporting Manager
Armistice Capital, LLC
Security
HELIUS MEDICAL TECHNOLOGIES, INC. Class A Common Stock, $0.001 par value per share
Symbol
HSDT
Shares outstanding
8,720,060 shares
Disclosed Ownership
871,134 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
15 May 2025, 15:16:09 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"ARMISTICE CAPITAL, LLC disclosed 10% ownership in HELIUS MEDICAL TECHNOLOGIES, INC. Class A Common Stock, $0.001 par value per share (HSDT) on 31 Mar 2025."

Quick Takeaways

  • ARMISTICE CAPITAL, LLC filed SCHEDULE 13G for HELIUS MEDICAL TECHNOLOGIES, INC. Class A Common Stock, $0.001 par value per share (HSDT).
  • Disclosed ownership: 10%.
  • Date of event: 31 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 15 May 2025, 15:16.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Armistice Capital, LLC 10% 871,134 0 871,134 /s/ Steven Boyd Steven Boyd - Managing Member
Steven Boyd 10% 871,134 0 871,134 /s/ Steven Boyd Steven Boyd

Sponsored